Capricorn prepares for February showdown
The firm’s board continues to push back against opposition among some shareholders to plans for a merger with Israeli independent New Med
The dispute between London-listed Capricorn Energy’s board and shareholders over the proposed merger with Israel’s New Med is likely to come to a head in early February, with an extraordinary general meeting planned for the first of the month. The board expects to hold a “vote on the combination on or around the same date”. The shareholder revolt is being led by London-based fund Palliser Capital, which owns 6.96pc of Capricorn shares but claims that shareholders representing more than 40pc “disapprove of the New Med deal”. The fund called for a general meeting back in December, stating that it, “as required by the articles [of incorporation]... must take place by 30 January 2023 at the late
Also in this section
24 March 2026
It is an unusual story of out with the new and in with the old, as America First Refining shows the US going back to trusted energy security developments
23 March 2026
A complex and sometimes contradictory web of factors that include unpredictable oil prices, the globalisation of LNG markets, the expansion of Middle Eastern sovereign capital and the growth of datacentre demand will shape the energy landscape beyond 2026
23 March 2026
The Strait of Hormuz crisis highlights how key waterways can become global chokepoints
20 March 2026
Attacks on key oil and LNG assets across the Gulf mean a prolonged supply disruption, with damage to Qatar’s export capacity undermining confidence in the global gas system






